Suppr超能文献

“白细胞介素-1受体拮抗剂”是人蜕膜细胞合成前列腺素的部分激动剂。

The "interleukin 1 receptor antagonist" is a partial agonist of prostaglandin synthesis by human decidual cells.

作者信息

Cole O F, Sullivan M H, Elder M G

机构信息

Institute of Obstetrics and Gynaecology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

出版信息

Prostaglandins. 1993 Dec;46(6):493-8. doi: 10.1016/0090-6980(93)90068-i.

Abstract

In many systems the interleukin-1 receptor antagonist opposes the effects of interleukin-1 beta. We considered that it might block interleukin-1 beta-stimulated prostaglandin production from human decidual cells. Very high levels of interleukin-1 receptor antagonist (> 1000 pg/ml) had limited inhibitory effects on IL-1 beta-stimulated PGE2 synthesis, and lower levels of antagonist (< 1000 pg/ml) increased the effects of IL-1 beta. Low concentrations of the antagonist alone (1-100 pg/ml) increased basal PGE2 production, whereas higher levels (10-100 ng/ml) had less effect. It seems, therefore, that in human decidua the "antagonist" is more accurately described as a partial agonist. It has been suggested that the IL-1 receptor antagonist could be used to inhibit decidual prostaglandin synthesis and thereby prevent preterm labor, but this report shows that caution should be exercised before using the receptor antagonist.

摘要

在许多系统中,白细胞介素-1受体拮抗剂可对抗白细胞介素-1β的作用。我们认为它可能会阻断白细胞介素-1β刺激人蜕膜细胞产生前列腺素。非常高浓度的白细胞介素-1受体拮抗剂(>1000 pg/ml)对白细胞介素-1β刺激的PGE2合成的抑制作用有限,而较低浓度的拮抗剂(<1000 pg/ml)则增强了白细胞介素-1β的作用。单独使用低浓度的拮抗剂(1-100 pg/ml)可增加基础PGE2的产生,而较高浓度(10-100 ng/ml)的作用则较小。因此,在人蜕膜中,“拮抗剂”更准确地应被描述为部分激动剂。有人提出白细胞介素-1受体拮抗剂可用于抑制蜕膜前列腺素的合成,从而预防早产,但本报告表明在使用该受体拮抗剂之前应谨慎行事。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验